Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/78856

In Collections

This item can be found in the following collections:

Mastrokolias, A.; Pool, R.; Mina, E.; Hettne, K.M.; Duijn, E. van; Mast, R.C. van der; ... ; Roon-Mom, W. van (2016)

Integration of targeted metabolomics and transcriptomics identifies deregulation of phosphatidylcholine metabolism in Huntington's disease peripheral blood samples

Article / Letter to editor
Introduction Metabolic changes have been frequently associated with Huntington's disease (HD). At the same time peripheral blood represents aminimally invasive sampling avenue with little distress to Huntington's disease patients especially when brain or other tissue samples are difficult to collect.Objectives We investigated the levels of 163 metabolites in HD patient and control serum samples in order to identify disease related changes. Additionally, we integrated the metabolomics data with our previously published next generation sequencing-based gene expression data from the same patients in order to interconnect the metabolomics changes with transcriptional alterations. Methods This analysis was performed using targeted metabolomics and flow injection electrospray ionization tandem mass spectrometry in 133 serum samples from 97 Huntington's disease patients (29 pre-symptomatic and 68 symptomatic) and 36 controls.Results By comparing HD mutation carriers with controls we...Show moreIntroduction Metabolic changes have been frequently associated with Huntington's disease (HD). At the same time peripheral blood represents aminimally invasive sampling avenue with little distress to Huntington's disease patients especially when brain or other tissue samples are difficult to collect.Objectives We investigated the levels of 163 metabolites in HD patient and control serum samples in order to identify disease related changes. Additionally, we integrated the metabolomics data with our previously published next generation sequencing-based gene expression data from the same patients in order to interconnect the metabolomics changes with transcriptional alterations. Methods This analysis was performed using targeted metabolomics and flow injection electrospray ionization tandem mass spectrometry in 133 serum samples from 97 Huntington's disease patients (29 pre-symptomatic and 68 symptomatic) and 36 controls.Results By comparing HD mutation carriers with controls we identified 3 metabolites significantly changed in HD (serine and threonine and one phosphatidylcholine-PC ae C36:0) and an additional 8 phosphatidylcholines (PC aa C38:6, PC aa C36:0, PC ae C38:0, PC aa C38:0, PC ae C38:6, PC ae C42:0, PC aa C36:5 and PC ae C36:0) that exhibited a significant association with disease severity. Using workflow based exploitation of pathway databases and by integrating our metabolomics data with our gene expression data from the same patients we identified 4 deregulated phosphatidylcholine metabolism related genes (ALDH1B1, MBOAT1, MTRR and PLB1) that showed significant association with the changes in metabolite concentrations.Conclusion Our results support the notion that phosphatidylcholine metabolism is deregulated in HD blood and that these metabolite alterations are associated with specific gene expression changes.Show less
Gene expression
Biomarkers
Disease progression
Neurodegenerative
Integrated analysis
All authors
Mastrokolias, A.; Pool, R.; Mina, E.; Hettne, K.M.; Duijn, E. van; Mast, R.C. van der; Ommen, G. van; Hoen, P.A.C. 't; Prehn, C.; Adamski, J.; Roon-Mom, W. van
Date
2016-08-01
Journal
Metabolomics
Volume
12
Pages
137
DOI
doi:10.1007/s11306-016-1084-8
Link
https://link.springer.com/article/10.1007/s11306-016-1084-8